| Serotonin | IC50 | 79.0 [1], 184.0 [2] |
| Serotonin | Ki | 110.0 [1], 126.0 [2], 130.0 [3], 170.0 [4], 250.0 [5] |
| Ergotamine | Ki | 14.0 [1], 16.0 [2], 22.0 [3], 40.0 [4] |
| 8-OH-Dpat | Ki | 1000.0 [1], 2500.0 [2] |
| Methiothepin | Ki | 1.0 [1], 100.0 [2] |
| 2-[3-(4-Fluorophenoxy)propyl]-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole | Ki | 13.0 [1], 55.0 [2] |
| Clozapine | Ki | 1000.0 [1] |
| Lysergide | Ki | 9.0 [1], 10.0 [2] |
| Ketanserin | Ki | 20000.0 [1] |
| Harmine | Ki | 10000.0 [1] |
| 5-Carboxamidotryptamine | Ki | 20.0 [1] |
| (R)-3-((2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidin-1-yl)sulfonyl)phenol | Ki | 63.1 [1], 65.0 [2] |
| 6-Methoxyharmalan | Ki | 10000.0 [1] |
| N,N-Diallyl-5-methoxytryptamine | Ki | 3311.31 [1], 10000.0 [2] |
| 7-Methoxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole | Ki | 10000.0 [1] |
| 5-Chloro-4-methyl-1,4-dihydroquinazolin-2-amine | Ki | 5.01 [1], 5.13 [2] |
| Benzyl N-[[(6aR,9S,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methyl]carbamate | Ki | 630.0 [1], 1000.0 [2] |
| 4-Methyl-1,4-dihydroquinazolin-2-amine;hydroiodide | Ki | 38.0 [1] |
| 5-(2-Pyridin-2-ylethyl)-5-azahexacyclo[5.4.1.02,6.03,10.04,8.09,12]dodecan-4-ol | Ki | 10000.0 [1] |
| 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-sulfonamide | Ki | 5000.0 [1] |
| Risperidone | Ki | 1000.0 [1] |
| Olanzapine | Ki | 1000.0 [1] |
| Sorafenib | Ki | 3296.0 [1] |
| Quetiapine | Ki | 1000.0 [1] |
| Aripiprazole | Ki | 1000.0 [1] |
| Sumatriptan | IC50 | 501.19 [1] |
| Spiperone | Ki | 63000.0 [1] |
| 4-Iodo-2,5-dimethoxyphenylisopropylamine | Ki | 1000.0 [1] |
| Harmaline | Ki | 10000.0 [1] |
| Tryptoline | Ki | 3200.0 [1] |
| 2-Methyl-5-hydroxytryptamine | Ki | 10000.0 [1] |
| Zacopride | Ki | 16000.0 [1] |
| Penfluridol | Ki | 1000.0 [1] |
| 3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine | Ki | 10000.0 [1] |
| 1-Naphthylpiperazine | Ki | 40.0 [1] |
| alpha-Methyltryptamine | Ki | 10000.0 [1] |
| 2-Bromolysergic acid diethylamide | Ki | 10.0 [1] |
| 5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide | IC50 | 10000.0 [1] |
| Harmalol | Ki | 10000.0 [1] |
| (1S,2R)-5-Methoxy-1-methyl-N,N-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine | Ki | 168.0 [1] |
| 5-Methoxy-1-methyl-2-(n-propylamino)tetralin | Ki | 2331.0 [1] |
| Tetrahydroharman | Ki | 10000.0 [1] |
| Tetrahydroharmine | Ki | 10000.0 [1] |
| Harmalan | Ki | 845.0 [1] |
| 2-Ethyl-5-methoxy-N,N-dimethyltryptamine | Ki | 4620.0 [1] |
| Benzonitrile, 3-fluoro-5-(2-(2-(fluoromethyl)-4-thiazolyl)ethynyl)- | Ki | 10000.0 [1] |
| Barettin | Ki | 10000.0 [1] |
| Naluzotan | Ki | 5000.0 [1] |
| 3-(2-Aminopyrimidin-4-yl)-1H-indol-4-ol | IC50 | 10000.0 [1] |
| CID 10028436 | Ki | 181.97 [1] |
| 4,9-Dihydro-7-methoxy-3H-pyrido(3,4b)indole | Ki | 10000.0 [1] |
| 1H-Indole-3-ethanamine, 5-methoxy-N,N-dimethyl-2-phenyl- | Ki | 5160.0 [1] |
| Unii-N4Y2V13I7F | Ki | 10000.0 [1] |
| 3-Amino-2-[4-(4-quinolin-2-ylpiperazin-1-yl)butyl]-5,6,7,8-tetrahydroquinazolin-4-one | IC50 | 1000.0 [1] |
| N-Methyllaurotetanine | Ki | 566.0 [1] |
| Thalictruberine | Ki | 2224.0 [1] |
| 1-(Naphthalen-2-yl)piperazine | Ki | 2100.0 [1] |
| CID 9847194 | IC50 | 10000.0 [1] |
| 2-Iodolysergic acid diethylamide | Ki | 10.0 [1] |
| N~2~-(3-Bromophenyl)-6,6-dimethyl-1,6-dihydro-1,3,5-triazine-2,4-diamine | Ki | 389.0 [1] |
| 2-Amino-5,6-dichloro-3,4-dihydroquinazoline | Ki | 43.0 [1] |
| 4-Imidazolidinone, 5-((6-bromo-1H-indol-3-yl)methylene)-2-imino-1,3-dimethyl- | Ki | 9621.0 [1] |
| Indole, 3-(2-(dimethylamino)ethyl)-5-methoxy-2-methyl- | Ki | 10450.0 [1] |
| 6-Methoxy-1-methyl-9H-pyrido[3,4-b]indole | Ki | 10000.0 [1] |
| 3-(1-Methyl-2-imidazoline-2-ylmethyl)pyridine | Ki | 10000.0 [1] |
| 2-Methyl-5-(2-(4-(quinolin-8-ylmethyl)piperazin-1-yl)ethoxy)quinoline | Ki | 3162.28 [1] |
| CID 10331436 | Ki | 10000.0 [1] |
| 2-Amino-5-[(Z)-(6-bromoindol-3-ylidene)methyl]-3-methylimidazol-4-ol | Ki | 5355.0 [1] |
| 5-[(E)-(5-Bromoindol-3-ylidene)methyl]-2-imino-1,3-dimethylimidazol-4-ol | Ki | 6725.0 [1] |
| Watasemycin A | Ki | 10000.0 [1] |
| Watasemycin B | Ki | 10000.0 [1] |
| 2-(2-Hydroxyphenyl)-4-thiazolecarbaldehyde | Ki | 10000.0 [1] |
| N-(3-(1-(2-(2-Methylquinolin-5-yloxy)ethyl)piperidin-4-ylmethyl)phenyl)methanesulfonamide | Ki | 1258.93 [1] |
| Ethyl 3-[(4-amino-1,3,5-triazaspiro[5.5]undeca-2,4-dien-2-yl)amino]benzoate | Ki | 457.0 [1] |
| 3-((2-Fluorothiazol-4-yl)ethynyl)-5-fluorobenzonitrile | Ki | 10000.0 [1] |
| N,N,N-Trimethylserotonin | Ki | 10000.0 [1] |
| 2-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-5-methyl-1,2,5-thiadiazolidine 1,1-dioxide | IC50 | 794.33 [1] |
| [3-(4-Fluoro-phenoxy)-propyl]-dimethyl-amine | Ki | 10000.0 [1] |
| 2-[4-[4-(7-(111C)Methoxynaphthalen-1-yl)piperazin-1-yl]butyl]-4-methyl-1,2,4-triazine-3,5-dione | Ki | 228.6 [1] |
| 4-N-(3-Bromophenyl)-1,3,5-triazaspiro[5.5]undeca-1,4-diene-2,4-diamine | Ki | 227.0 [1] |
| 2-[4-[4-(3-Methoxyphenyl)piperazin-1-yl]butyl]-4-methyl-1,2,4-triazine-3,5-dione | Ki | 10000.0 [1] |
| N,N-Dimethyl-3,4-dihydroquinazolin-2-amine | Ki | 2800.0 [1] |
| 1-((S)-2-Aminopropyl)-1H-indazol-6-ol | Ki | 10000.0 [1] |
| 2-Amino-5-[(Z)-(5-bromoindol-3-ylidene)methyl]-1H-imidazol-4-ol | Ki | 89.0 [1] |
| 2-Amino-5-[(Z)-indol-3-ylidenemethyl]-1H-imidazol-4-ol | Ki | 101.0 [1] |
| Pulicatin A | Ki | 10000.0 [1] |
| Pulicatin B | Ki | 10.0 [1] |
| Aerugine | Ki | 10000.0 [1] |
| Pulicatin G | Ki | 10000.0 [1] |
| Pulicatin F | Ki | 10000.0 [1] |
| 2-Amino-5-[(Z)-(4-bromoindol-3-ylidene)methyl]-3-methylimidazol-4-ol | Ki | 1282.0 [1] |
| 2-Amino-5-[(Z)-(5-bromoindol-3-ylidene)methyl]-3-methylimidazol-4-ol | Ki | 2332.0 [1] |
| 2-Amino-5-[(Z)-(7-bromoindol-3-ylidene)methyl]-3-methylimidazol-4-ol | Ki | 1550.0 [1] |
| 5-[(Z)-(4-Bromoindol-3-ylidene)methyl]-1-methyl-2-(methylamino)imidazol-4-ol | Ki | 1454.0 [1] |
| 5-[(Z)-(7-Bromoindol-3-ylidene)methyl]-1-methyl-2-(methylamino)imidazol-4-ol | Ki | 1425.0 [1] |
| 5-[(Z)-(4-Bromoindol-3-ylidene)methyl]-2-imino-1,3-dimethylimidazol-4-ol | Ki | 7828.0 [1] |
| 5-[(Z)-(4-Bromoindol-3-ylidene)methyl]-2-(methylamino)-1H-imidazol-4-ol | Ki | 3372.0 [1] |
| 5-[(Z)-(7-Bromoindol-3-ylidene)methyl]-2-(methylamino)-1H-imidazol-4-ol | Ki | 3324.0 [1] |
| 5-[(Z)-(4-Bromoindol-3-ylidene)methyl]-1,3-dimethyl-2-methyliminoimidazol-4-ol | Ki | 5080.0 [1] |
| 5-[(Z)-(5-Bromoindol-3-ylidene)methyl]-1,3-dimethyl-2-methyliminoimidazol-4-ol | Ki | 9118.0 [1] |